AD

Active Director Director DIN 08682575
DIN 08682575 First appointment Jan 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value •••• Premium profile

About Arti Devi

Data last updated:

Arti Devi is a Director at Cerxa Lifesciences And Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals. Cerxa Lifesciences And Pharmaceuticals Private Limited reported revenue of ₹3.3 Lakh (FY 2024).

DIN 08682575
Primary Designation Director
Industry Chemicals
First Appointment 29 Jan 2020
Oldest Company Age 6 yrs
Largest company Cerxa Lifesciences And Pharmaceuticals Private Limited · ₹3.3 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Jan 20202020₹3.3 Lakh (FY 2024)Active

Board colleagues of Arti Devi

Directorship timeline

Open interactive timeline →
Cerxa Lifesciences And Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Arti Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arti Devi

Arti Devi currently holds 1 directorship: Cerxa Lifesciences And Pharmaceuticals Private Limited (Director, since 29 Jan 2020, revenue ₹3.3 Lakh (FY 2024)).

Arti Devi was first appointed on 29 Jan 2020 as Director at Cerxa Lifesciences And Pharmaceuticals Private Limited.

The current boards of Arti Devi's companies include Kumari Madhumala (Cerxa Lifesciences And Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available